Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 15 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

1135 Tumor intrinsic PDL1 promotes resistance to PARP inhibitors (PARPi) and select chemotherapies through Chk2 stabilization in bladder cancer

  • Anja N Holtz1
  • Jordan P Wentworth2
  • Tyler J Curiel2
  1. 1Dartmouth College, Hanover, NH, USA
  2. 2Dartmouth Cancer Center, Lebanon, NH, USA
Open at sourcePDFDOICite

Related

  1. Optimized alkyne-modified pyridylpiperazine efflux pump inhibitors overcome intrinsic macrolide resistance in multidrug-resistant Klebsiella pneumoniae isolates
    Cécilia Sobieski, Virginie Meurillon, Jonathan Chatagnon +16
    npj Antimicrobials and ResistancePeer-reviewedCC BYFull textGeneral biologyMedicinal chemistry & drug discoveryHAL
  2. CDK8 remodels the tumor microenvironment and promotes resistance to KRASG12D inhibitors and daraxonrasib in PDAC
    Kathleen M. McAndrews, Krishnan K. Mahadevan, Bingrui Li +29
    The EMBO JournalPeer-reviewedCC BY10 citedOncologyOpenAlex
  3. Pdk1-dependent metabolic heterogeneity promotes aggressive colorectal cancer through cell-intrinsic interferon signaling
    J. Calviello, L. Poeltl, A. Mira +17
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  4. Opportunities and challenges in the development of evolving EGFR inhibitors to overcome EGFR TKIs resistance
    Yi Chen, Qiu-pei Liu, Si-jie Yang +3
    Acta Pharmacologica SinicaPeer-reviewedLicence not statedFull text1 citedGeneral medicinePMC
  5. LARP1-mediated stabilization of CD73 mRNA promotes immune escape in triple-negative breast cancer
    Xia Qiu, Jiying Shen, Yingxin Guan +5
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textPhysiologyCrossrefPMC

Cite

BibTeXRIS
BibTeX
@article{holtz20261135,
  title = {{1135 Tumor intrinsic PDL1 promotes resistance to PARP inhibitors (PARPi) and select chemotherapies through Chk2 stabilization in bladder cancer}},
  author = {Anja N Holtz and Jordan P Wentworth and Tyler J Curiel},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.1135},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.1135},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 1135 Tumor intrinsic PDL1 promotes resistance to PARP inhibitors (PARPi) and select chemotherapies through Chk2 stabilization in bladder cancer
AU  - Anja N Holtz
AU  - Jordan P Wentworth
AU  - Tyler J Curiel
PY  - 2026
DA  - 2026/11/04
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.1135
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.1135
SN  - 2051-1426
ER  -